Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Lux Ventures II Sidecar LP — GENOCEA BIOSCIENCES, INC. insider · InsiderLens

Home / Insiders / Lux Ventures II Sidecar LP

Lux Ventures II Sidecar LP

Former 10% Owner at GENOCEA BIOSCIENCES, INC. · on record since Feb 11, 2014
10% owner at GENOCEA BIOSCIENCES, INC. · on record since Feb 4, 2014
Former 10% Owner at EVERSPIN TECHNOLOGIES INC. · on record since Oct 17, 2016
Former 10% Owner at Cerulean Pharma Inc. · on record since Apr 15, 2014
10% owner at Cerulean Pharma Inc. · on record since Apr 10, 2014
10% owner at EVERSPIN TECHNOLOGIES INC. · on record since Oct 7, 2016
10% owner at Kala Pharmaceuticals, Inc. · on record since Jul 19, 2017

Insider trading activity of Lux Ventures II Sidecar LP

No transactions on record for Lux Ventures II Sidecar LP.

Track record of Lux Ventures II Sidecar LP

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Lux Ventures II Sidecar LP

Co-insiders of Lux Ventures II Sidecar LP

Lux Capital Management, LLCCerulean Pharma Inc. +3
Lux Venture Associates II, LLCCerulean Pharma Inc. +3
Lux Venture Partners II, L.P.Cerulean Pharma Inc. +3
Lux Ventures II, L.P.Cerulean Pharma Inc. +3
Polaris Venture Management Co. V, L.L.C.Cerulean Pharma Inc. +2
Polaris Venture Partners Entrepreneurs' Fund V, L.P.Cerulean Pharma Inc. +2
Polaris Venture Partners Founders' Fund V, L.P.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Cerulean Pharma Inc. +2

Polaris Venture Partners Special Founders' Fund V, L.P.Cerulean Pharma Inc. +2

Polaris Venture Partners V, L.P.Cerulean Pharma Inc. +2

CVF, LLCCerulean Pharma Inc. +1

TEPPER ROBERT ICerulean Pharma Inc. +1

Aakalu Girish NGENOCEA BIOSCIENCES, INC.

Aggarwal AnujEVERSPIN TECHNOLOGIES INC.

Aggarwal SanjeevEVERSPIN TECHNOLOGIES INC.

Alfieri MichaelGENOCEA BIOSCIENCES, INC.

Andre ThomasEVERSPIN TECHNOLOGIES INC.

Arbuckle Stuart ACerulean Pharma Inc.

Armour NormEVERSPIN TECHNOLOGIES INC.

Baker Bros. Advisors (GP) LLCKala Pharmaceuticals, Inc.

BAKER BROS. ADVISORS LPKala Pharmaceuticals, Inc.

BAKER FELIXKala Pharmaceuticals, Inc.

BAKER JULIANKala Pharmaceuticals, Inc.

BARRIS PETER JGENOCEA BIOSCIENCES, INC.

BASKETT FORESTGENOCEA BIOSCIENCES, INC.

BATE KENNETHGENOCEA BIOSCIENCES, INC.

Bazemore ToddKala Pharmaceuticals, Inc.

Behbahani AliGENOCEA BIOSCIENCES, INC.

BELOFF GREGGCerulean Pharma Inc.

Berenbaum DanielEVERSPIN TECHNOLOGIES INC.

Berger Chaim D.Kala Pharmaceuticals, Inc.

Bessemer Venture Partners VII Institutional L.P.Cerulean Pharma Inc.

Bessemer Venture Partners VII L.P.Cerulean Pharma Inc.

Billerbeck Darin GEVERSPIN TECHNOLOGIES INC.

Bitterman KevinGENOCEA BIOSCIENCES, INC.

Blanchard Cheryl RCerulean Pharma Inc.

Blumenkranz Mark S.Kala Pharmaceuticals, Inc.

Bosley KatrineGENOCEA BIOSCIENCES, INC.

Brazzell Romulus KKala Pharmaceuticals, Inc.

Carroll PamelaGENOCEA BIOSCIENCES, INC.

Carvajal AlejandraCerulean Pharma Inc.

CAXTON CORPKala Pharmaceuticals, Inc.

CDK ASSOCIATES, L.L.C.Kala Pharmaceuticals, Inc.

Chang CarmenGENOCEA BIOSCIENCES, INC.

Chen HongmingKala Pharmaceuticals, Inc.

Clark William DGENOCEA BIOSCIENCES, INC.

Colman Yonatan C.Kala Pharmaceuticals, Inc.

Conley KevinEVERSPIN TECHNOLOGIES INC.

Cooper Ronald Harold WilfredGENOCEA BIOSCIENCES, INC.

Cooper William EarlEVERSPIN TECHNOLOGIES INC.

Crane Alan LCerulean Pharma Inc.

No transactions on record. Reset filters